%0 Journal Article
%T Robotic-assisted mediastinal surgery: the first Chinese series of 167 consecutive cases
%A Hanyue Li
%A Jia Huang
%A Jiantao Li
%A Qingquan Luo
%A Yunhai Yang
%J SCIE-indexed Journal
%D 2018
%R 10.21037/jtd.2018.04.138
%X In June 2000, the approval of the Da Vinci surgical system by the American FDA marked the birth of the first commercial surgical robot being applied in an operating room. There has been a surge in the number of robotic thoracic surgeries since the first report of robotic lobectomy in 2002 by Melfi et al. (1). In 2016, mainland China completed 2,119 robotic thoracic operations, and completed a total of 4,737 cases over the years, including 1,180 mediastinal mass resections. There have been many reports on the practice of robotic-assisted mediastinal surgery, which suggests that the robotic system seems ideally suited for mediastinal lesions and has satisfactory post-operative outcomes (2-5). Since our first robotic mediastinal mass resection in 2009 to June 2017, our center has performed 167 robotic mediastinal surgeries. Here, we would like to report the results of our 167 cases; this study is currently the largest retrospective single-center study in mainland China. We would also like to share our experience with the use of the da Vinci surgical system for mediastinal mass resection
%U http://jtd.amegroups.com/article/view/21547/html